Citation:Sause W, Kolesar P, Taylor S IV, Johnson D, Livingston R, Komaki R, et al 2000
Sause W, Kolesar P, Taylor S IV, Johnson D, Livingston R, Komaki R, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000 Feb;117(2):358-64 Available from: http://www.ncbi.nlm.nih.gov/pubmed/10669675.
Compare quality appraisals for each clinical question
- What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?
- What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?